Regular Article
Increased IL-6 and IL-8 Levels in Cervicovaginal Secretions of Patients with Cervical Cancer,☆☆,

https://doi.org/10.1006/gyno.1999.5358Get rights and content

Abstract

Objective.Conflicting data exist on IL-6 production by human papillomavirus (HPV) immortalized cell lines and several cervical carcinoma cell lines. However, no information has been reported on the levels of cytokines in cervicovaginal washings in relation to cervical neoplasia. The aim of this study was to investigate whether local production of IL-6 could be found and whether the level of this cytokine was related to the severity of cervical neoplasia. IL-8 was measured to obtain additional information on an inflammatory cytokine with possible epithelial origin.

Methods.Cervicovaginal washings and sera were obtained from 35 patients with invasive cervical cancer, 62 patients with cervical intraepithelial neoplasia (CIN), and 25 control subjects. IL-6 and IL-8 levels were determined by ELISA. HPV DNA in cervical smears was detected by a HPV-16-specific PCR method and additionally by CPI/IIG PCR. Histological analysis of the inflammatory infiltrate was performed on hematoxylin–eosin-stained tissue sections.

Results.In the patients with cervical cancer, those with CIN, and the controls, the median IL-6 concentration in cervicovaginal washings was 171 pg/ml (interquartile range: 54–780), 22 pg/ml (<2–73), and < 2 pg/ml (<2–<2), respectively. For IL-8, the levels were 2756 pg/ml (1651–7107), 489 pg/ml (248–1158), and 631 pg/ml (346–897), respectively. In most subjects the local levels were much higher than in serum. Local IL-6 and IL-8 levels were significantly higher in patients with cervical carcinoma compared with CIN patients and controls. Likewise, local IL-6 levels were increased in patients with CIN compared with controls. No relation was found between cytokine levels and CIN grade or between cytokine levels and the inflammatory infiltrate scored by histological analysis.

Conclusions.There is local production of IL-6 and IL-8 in cervicovaginal secretions, and the production of IL-6 was related to the severity of cervical neoplasia.

References (41)

  • A Quesnel et al.

    Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women

    J Immunol Methods

    (1997)
  • H Zur Hausen

    Papillomavirus infections—a major cause of human cancers

    Biochim Biophys Acta

    (1996)
  • M Maiman et al.

    Human immunodeficiency virus infection and invasive cervical carcinoma

    Cancer

    (1993)
  • R Halpert et al.

    Human papillomavirus and lower genital neoplasia in renal transplant patients

    Obstet Gynecol

    (1986)
  • MB Parr et al.

    Mucosal Immunity in the Female and Male Reproductive Tracts

    Handbook of Mucosal Immunology

    (1994)
  • FW van Ginkel et al.

    Mucosal immunity to human papillomavirus in the female reproductive tract

    Papillomavirus Rep

    (1997)
  • P Brandtzaeg

    Overview of the mucosal immune system

    Curr Topics Microbiol Immunol

    (1989)
  • CD Woodworth et al.

    Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines

    Am J Pathol

    (1993)
  • G Castrilli et al.

    Interleukin 1-alpha and interleukin 6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells

    Br J Cancer

    (1997)
  • E Tartour et al.

    Analysis of interleukin 6 gene expression in cervical neoplasia using a quantitative polymerase chain reaction assay: evidence for enhanced interleukin 6 gene expression in invasive carcinoma

    Cancer Res

    (1994)
  • Cited by (0)

    This study was supported by the European Cancer Center, Amsterdam, The Netherlands.

    ☆☆

    Part of this work was presented as a poster presentation at the 13th European Immunology Meeting, June 22–25, 1997, Amsterdam, The Netherlands.

    Ogra, P, LMestecky, JLamm, M, EStrober, WMcGhee, J, RBienenstock, J

    View full text